Cargando…

Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum β-Lactamase Production in Proteus mirabilis Bacteremia

BACKGROUND/AIMS: We evaluated the clinical features of ciprofloxacin-resistant Proteus mirabilis bacteremia and risk factors for ciprofloxacin resistance. METHODS: From October 2000 to July 2009, 37 patients with clinically significant P. mirabilis bacteremia were identified and data from patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohn, Kyung Mok, Kang, Cheol-In, Joo, Eun-Jeong, Ha, Young Eun, Chung, Doo Ryeon, Peck, Kyong Ran, Lee, Nam Yong, Song, Jae-Hoon
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056262/ https://www.ncbi.nlm.nih.gov/pubmed/21437168 http://dx.doi.org/10.3904/kjim.2011.26.1.89

Ejemplares similares

The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea
por: Ahn, Jin Young, et al.
Publicado: (2017)

Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients
por: Nham, Eliel, et al.
Publicado: (2020)

Pulmonary Pneumatocele in a Pneumonia Patient Infected with Extended-Spectrum β-Lactamase Producing Proteus mirabilis
por: Ryou, Sung Hyeok, et al.
Publicado: (2015)

The Assessment of Proteus mirabilis Susceptibility to Ceftazidime and Ciprofloxacin and the Impact of These Antibiotics at Subinhibitory Concentrations on Proteus mirabilis Biofilms
por: Kwiecińska-Piróg, Joanna, et al.
Publicado: (2013)

Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates
por: Shaaban, Mona, et al.
Publicado: (2022)

Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase
por: Seok, Hyeri, et al.
Publicado: (2018)

Clinical and Molecular Epidemiology of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli over a 6-Year Period
por: Kang, Cheol-In, et al.
Publicado: (2013)

The Ciprofloxacin Impact on Biofilm Formation by Proteus Mirabilis and P. Vulgaris Strains
por: Kwiecinska-Pirog, Joanna, et al.
Publicado: (2016)

Native valve endocarditis due to extended spectrum β-lactamase producing Klebsiella pneumoniae
por: Jung, Hyun-Ae, et al.
Publicado: (2014)

Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections
por: Park, So Yeon, et al.
Publicado: (2017)

Usefulness of C-Reactive Protein for Evaluating Clinical Outcomes in Cirrhotic Patients with Bacteremia
por: Ha, Young Eun, et al.
Publicado: (2011)

Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
por: Cheong, Hae Suk, et al.
Publicado: (2016)

Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis
por: Joo, Eun-Jeong, et al.
Publicado: (2019)

720 Clinical Features and Risk Factors for Mortality of Stenotrophomonas maltophilia Bacteremia in Patients with Hematologic Malignancies
por: Cho, Sun Young, et al.
Publicado: (2014)

In vitro efficacy of cephamycins against multiple extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae isolates from dogs and cats
por: KUSUMOTO, Mizuki, et al.
Publicado: (2023)

ECA-immunogenicity of Proteus mirabilis strains
por: Duda, Katarzyna Anna, et al.
Publicado: (2009)

Unexpected source of Proteus mirabilis bacteraemia
por: Nagiah, Sureshkumar, et al.
Publicado: (2018)

Arthrite septique à Proteus mirabilis
por: Sbiti, Mohammed, et al.
Publicado: (2017)

Multivalvular infective endocarditis with Proteus mirabilis
por: Bux, Amber, et al.
Publicado: (2022)

Pyoderma caused by Proteus mirabilis in sheep
por: Abdollahi, Mostafa, et al.
Publicado: (2022)

Pericarditis caused by Proteus mirabilis in sheep
por: Najd Ghahremani, Abolfazl, et al.
Publicado: (2023)

VEB-1 extended-spectrum β-lactamase-producing multidrug-resistant Proteus mirabilis sepsis outbreak in a neonatal intensive care unit in India: clinical and diagnostic implications
por: Jain, Sarika, et al.
Publicado: (2016)

Complete Genome Sequence of the Extensively Drug-Resistant Extended-Spectrum β-Lactamase-Producing Proteus mirabilis Isolate HK294, Obtained from Poultry Feces in Hong Kong
por: Biggel, Michael, et al.
Publicado: (2023)

IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis
por: Dixon, Nyssa, et al.
Publicado: (2016)

THE NATURE OF COLICIN K FROM PROTEUS MIRABILIS
por: Jesaitis, Margeris A.
Publicado: (1970)

Genomic and Ecogenomic Characterization of Proteus mirabilis Bacteriophages
por: Alves, Diana R., et al.
Publicado: (2019)

Proteus mirabilis Biofilm: Development and Therapeutic Strategies
por: Wasfi, Reham, et al.
Publicado: (2020)

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae
por: Park, Ga Eun, et al.
Publicado: (2021)

407 Impact of methicillin-resistance on mortality, hospital stay and medical cost in patients with Staphylococcus aureus bacteremia and endocarditis: A meta-analysis
por: Joo, Eun-Jeong, et al.
Publicado: (2014)

Draft Genome Assemblies of Proteus mirabilis ATCC 7002 and Proteus vulgaris ATCC 49132
por: Minogue, T. D., et al.
Publicado: (2014)

1200. Molecular Epidemiology of Cephalosporinases and Extended Spectrum β-Lactamases (ESBLs) in Proteus mirabilis Isolates From Croatia: Following the Spread of Resistance Determinants Between Long-Term Care Facilities and the Community
por: Mestrovic, Tomislav, et al.
Publicado: (2018)

Radial and Spiral Stream Formation in Proteus mirabilis Colonies
por: Xue, Chuan, et al.
Publicado: (2011)

Biofilm inhibition and pathogenicity attenuation in bacteria by Proteus mirabilis
por: Yu, Shichen, et al.
Publicado: (2018)

A Case of Tetraplegia after Proteus mirabilis Infection
por: Jitsuiki, Kei, et al.
Publicado: (2017)

Multidrug-Resistant Proteus mirabilis Strain with Cointegrate Plasmid
por: Shelenkov, Andrey, et al.
Publicado: (2020)

Complete Genome Sequence of Proteus mirabilis Siphophage Saba
por: Nguyen, James, et al.
Publicado: (2019)

Complete Genome Sequence of Proteus mirabilis Siphophage Stubb
por: Bourgeois, Taylor A., et al.
Publicado: (2019)

Complete Genome Sequence of Proteus mirabilis Phage Mydo
por: Jones, Benjamin T., et al.
Publicado: (2019)

Complete Genome Sequence of Proteus mirabilis Phage Myduc
por: Tran, Jennifer, et al.
Publicado: (2019)

Association of Proteus mirabilis and Providencia stuartii Infections with Diabetes
por: Rus, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hkh0ftqmdrqu64n36a071u72v7